Blood test may predict stomach cancer return after surgery
NCT ID NCT07507916
First seen Apr 09, 2026 · Last updated May 16, 2026 · Updated 6 times
Summary
This study tests whether a simple blood test that looks for tumor DNA (ctDNA) can help doctors decide on the best treatment after surgery for stomach or gastroesophageal junction cancer. About 32 people with stage III or IVA cancer will have their blood checked at several times before and after surgery. The goal is to see if this approach can improve the chance of staying cancer-free for at least one year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.